Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Share News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Instem acquisition by Ichor sanctioned by UK court

Thu, 16th Nov 2023 19:30

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Andrada Mining Ltd - African technology metals mining company with a portfolio of mining and exploration assets in Namibia - Says it has received USD25 million in funding from Orion Mine Finance. Says the funding consists of GBP12.5 million unsecured tin royalty, USD2.5 million equity subscription for 30.5 million shares, and USD10 million convertible loan note. Says the tin royalty is allocated to increasing tin production at its Uis mine in Namibia. Says the remaining USD12.5 million will accelerate the lithium and tantalum revenue streams, including the expansion of Uis and exploration drilling across all of its licences. Chief Executive Anthony Viljoen says: "We are pleased to announce drawdown of the Orion funding, following the fulfilment of all conditions. This partnership with Orion will not only enable the expansion of tin production up to 2 000 tpa, but will also allow us to accelerate our wider lithium and tin development surrounding our Uis mine."

----------

Bushveld Minerals Ltd - South Africa-focused vanadium producer and energy storage solutions provider - Says finance director Tanya Chikanza resigns, giving six months' notice. Says it is investigating Chikanza regarding alleged misconduct which relates to a failure to disclose a material conflict of interest. Says it has suspended her from contractual appointment with immediate effect. Says Janandre Lamprecht will become acting finance director.

----------

Agronomics Ltd - investor in the cellular agriculture field - Says portfolio company Solar Foods Oy raises EUR8 million in series B financing round via Finnish investment organiser Springvest Oyj. Notes that existing investors have also participated in a private placement which will close in two weeks. Says existing investors include Happiness Capital and Lifeline Ventures. Notes that it has invested EUR6 million in Solar Foods so far.

----------

Instem PLC - Staffordshire, England-based provider of IT services to life sciences market - Says its proposed acquisition by Ichor Management Ltd Bidco, which is controlled by funds managed by Archimed SAS, has been sanctioned by the UK high court. Says scheme expected to become effective on November 21, with shares to be cancelled on London's AIM market.

----------

SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Launches placing of shares at 19 pence per share to raise at least GBP3.0 million. Launches separate retail offer to raise up to GBP250,000 from existing shareholders. Says proceeds will be used to advance oral and inflamation programmes, roll-out of Axis-PS, study and commercialisation of acne treatment and as working capital. Chief executive Stuart Ashman says: "The funds we are looking to raise are to help with the current commercialisation and development strategy of AxisBiotix in skin health, with our latest venture beginning in acne, as well as providing a stronger financial base to support our strategic partnering discussions around three of our other business pillars."

----------

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
10 May 2023 13:05

SkinBioTherapeutics pleased with progress on two fronts

(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics said in an update on Wednesday that its partner Sederma, a division of Croda International, was planning to undertake additional studies on SkinBiotix.

Read more
10 May 2023 11:59

SkinBioTherapeutics says Sederma to undertake more SkinBiotix studies

(Alliance News) - SkinBioTherapeutics PLC on Wednesday said that a partner has plans to undertake additional studies on SkinBiotix, which could enhance its commercial potential.

Read more
28 Mar 2023 12:25

IN BRIEF: SkinBioTherapeutics shares plunge on widened interim loss

SkinBioTherapeutics PLC - skin health-focused life sciences firm - Says interim revenue jumps to GBP76,985 in the six months to December 31, from GBP21,949 a year before. Pretax loss widens to GBP1.4 million from GBP1.2 million, as operational costs climb to GBP918,103 from GBP764,750. In 2023, says focus is on reaching commercial traction with Croda, launching AxisBiotix-Ps into Europe, developing an acne product, among others targets.

Read more
28 Mar 2023 10:40

AIM WINNERS & LOSERS: Unbound soars on potential takeover offer

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
7 Mar 2023 12:36

SkinBioTherapeutics receives Spanish health approval for AxisBioTix-Ps

(Alliance News) - SkinBioTherapeutics PLC on Tuesday said it received Spanish health authority authorisation for AxisBioTix-Ps, its food supplement to treat symptoms associated with psoriasis.

Read more
23 Jan 2023 15:48

UK shareholder meetings calendar - next 7 days

Tuesday 24 January 
C4X Discovery Holdings PLCAGM
Marston's PLCAGM
Smiths News PLCAGM
Wednesday 25 January 
City of London Group PLCGM re proposed share distribution and cancellation
Doric Nimrod Air One LtdEGM re special resolution to disapply the pre-emption rights
Infrastructure India PLCAGM
Lowland Investment Co PLCAGM
Majedie Investments PLCAGM
Majedie Investments PLCGM re appointment of the new investment manager
Thursday 26 January 
Auction Technology Group PLCAGM
Barings Emerging EMEA Opportunities PLCAGM
Britvic PLCAGM
Greencore Group PLCAGM
Henderson European Focus Trust PLCAGM
Friday 27 January 
Avon Protection PLCAGM
Henderson Far East Income LtdAGM
Ixico PLCAGM
NB Global Monthly Income Fund LtdEGM re proposed managed wind-down
On The Beach Group PLCAGM
Pathfinder Minerals PLCGM re capital raise
Serica Energy PLCGM re consideration shares approval
Treatt PLCAGM
Monday 30 January 
Bluebird Merchant Ventures LtdAGM
Contango Holdings PLCAGM
Hollywood Bowl Group PLCAGM
SkinBioTherapeutics PLCGM re annual report review
Starwood European Real Estate Finance LtdEGM re capital return 
Webis Holdings PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
22 Dec 2022 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 December 
Plexus Holdings PLCAGM
Wildcat Petroleum PLCAGM
Monday 26 December 
no events scheduled 
Tuesday 27 December 
Zambeef Products PLCAGM
Wednesday 28 December 
Evrima PLCAGM
Greencare Capital PLCGM re proposed name change
Lift Global Ventures PLCGM re proposed expansion within the energy sector
Thursday 29 December 
Amte Power PLCAGM
ADVFN PLCAGM
Genedrive PLCAGM
Hotel Chocolat Group PLCAGM
Lekoil LtdEGM re proposed settlement and name change
Online Blockchain PLCAGM
PetroNeft Resources PLCAGM
SkinBioTherapeutics PLCAGM
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
21 Dec 2022 11:06

UPDATE: SkinBioTherapeutics raises GBP2.6 million; annual loss widens

(Alliance News) - SkinBioTherapeutics PLC on Wednesday said it raised GBP2.6 million in total through its share placing and retail offer.

Read more
21 Dec 2022 10:59

SkinBioTherapeutics raises GBP2.6 million from placing, retail offer

(Alliance News) - SkinBioTherapeutics PLC on Wednesday said it raised GBP2.6 million in total through its share placing and retail offer.

Read more
16 Dec 2022 21:53

TRADING UPDATES: Dev Clever to cancel shares; Tintra raises funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
31 Aug 2022 12:55

SkinBioTherapeutics shares fall as probiotic AxisBiotix-PS sales drop

(Alliance News) - SkinBioTherapeutics PLC on Wednesday said the sales of its psoriasis food supplement AxisBiotix-PS were lower than expected and said it found a form of bacteria that prevents gum disease.

Read more
24 Aug 2022 10:43

OptiBiotix shares plunge on "very difficult trading" in half-year

(Alliance News) - OptiBiotix Health PLC on Wednesday lamented a strenuous half-year but eyed growing sales and business, seeing itself in a strong position.

Read more
28 Jun 2022 12:19

IN BRIEF: OptiBiotix Health annual profit up; confident in prospects

OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Reports higher profit and revenue in 2021 as probiotic business sells more. Pretax profit rises to GBP6.2 million from GBP5.7 million in 2020. Revenue from contracts with customers grows 45% to GBP2.2 million from GBP1.5 million.

Read more
13 Jun 2022 20:24

IN BRIEF: SkinBioTherapeutics unaware of reason for share price drop

SkinBioTherapeutics PLC- Skin health-focused life sciences company - Says it is not aware of any "material commercial or operational" reason for the fall in its share price on Monday. Adds that it continues to focus on driving sales of its AxisBiotix-Ps probiotic food supplement, which holds a subscriber-retention rate of more than 80%.

Read more
29 Mar 2022 13:39

IN BRIEF: SkinBioTherapeutics loss widens as underperforms in US

SkinBioTherapeutics PLC- Skin health-focused life sciences company - Says pretax loss widens to GBP1.2 million in six months to December 31, from GBP628,241 a year earlier. US market penetration with its only product launched in October 2021, AxisBiotix-Ps, for treating Psoriasis, was slower than expected, company adds. Revenue for the half comes in at GBP21,949, against none a year earlier. For the financial year ending in June, the company expects revenue materially below expectations, it warns.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.